According to a new report published by Allied Market Research, titled, “Biopsy Devices Market by Type, Application, Imaging Technology, and End User: Global Opportunity Analysis and Industry Forecast, 2019-2026,” the global biopsy devices market size was valued at $2,728 million in 2018, and is projected to reach $4,310 million by 2026, growing at a CAGR of 5.9% from 2019 to 2026.
𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :
The major companies profiled in this report include Argon Medical Devices, Inc., B. Braun Melsungen AG, Becton Dickinson and Company (C.R. Bard, Inc.), Boston Scientific Corporation, Cardinal Health, Inc., Cook Medical, Inc., Danaher Corporation (Leica Microsystem), Fujifilm Holdings Corp., Hologic, Inc., and Medtronic plc.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/1424
𝐊𝐄𝐘 𝐅𝐈𝐍𝐃𝐈𝐍𝐆𝐒 𝐎𝐅 𝐓𝐇𝐄 𝐒𝐓𝐔𝐃𝐘
- Based on product, the needle-based biopsy instruments segment held 37.48% share in the global market in 2018.
- Based on application, the breast biopsy segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.
- Based on imaging technology, the CT scan biopsy segment exhibits fastest growth and is expected to grow at a CAGR of 6.6% from 2019 to 2026.
- Based on end user, the hospital segment held 40.16% share in the global market in 2018.
- Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 7.1% during the forecast period.
𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/1424
The global biopsy devices market is currently dominated by conventional biopsy technologies such as needle biopsy and surgical biopsy. The cost of conventional biopsy procedure is less than that of advanced image-guided biopsy procedures, owing to their wider availability. Increase in prevalence of chronic diseases and rise in disposable income in developing economies fuel the adoption of novel biopsy procedures. Moreover, rise in awareness for diagnosis of diseases fosters the demand for integrated biopsy technologies such as MRI-guided breast biopsy. However, low income and lack of proper medical attention in the developing countries hamper the growth of the biopsy devices market.
Based on product, the needle-based biopsy instruments segment dominated the biopsy devices industry in 2018 due to rise in number of breast cancer, gastrointestinal tract diseases, and soft tissue sarcomas. Another factor that drives the growth of the segment is aspiration biopsy needles are non–invasive and provide efficient sample collection.
Depending on application, the breast biopsy segment accounted for the highest revenue share in biopsy devices market in 2018 and is expected to maintain its dominance during the forecast period owing to rise in number of breast cancer patients. In addition, increase in public awareness for disease screening and technological advancement in biopsy devices is expected to drive the growth of the biopsy devices market.
𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/Biopsy-Devices-market
𝐎𝐭𝐡𝐞𝐫 𝐓𝐫𝐞𝐧𝐝𝐢𝐧𝐠 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
205, Portland, OR 97220
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060